NEXGEL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
NEXGEL, INC. (NXGL) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 5.44 million shares for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2026-03-31
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2023-12-31 was -2.75M shares.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2023-09-30 was 0.00 shares.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2023-06-30 was 82.04M shares.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2023-03-31 was 30.43M shares.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2024 was 5.44M shares, a 95.04% decline from fiscal 2023.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2023 was 109.72M shares, a 1930910.21% increase from fiscal 2022.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2022 was 5.68K shares, a 85.62% decline from fiscal 2021.
- NEXGEL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2021 was 39.52K shares, a 76.67% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | 5.44M shares 10-K · filed 2026-03-31 | ||||
| 2023-12-31 | -2.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -2.75M shares derived: sum of 2 quarters · filed 2025-03-27 | 79.29M shares derived: sum of 3 quarters · filed 2025-03-27 | 109.72M shares 10-K · filed 2025-03-27 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 82.04M shares derived: sum of 2 quarters · filed 2023-11-13 | 112.47M shares 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | 82.04M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 112.47M shares 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 30.43M shares 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | 5.68K shares 10-K · filed 2023-03-28 | ||||
| 2021-12-31 | -1.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -1.34M shares derived: sum of 2 quarters · filed 2023-03-28 | 39.52K shares 10-K · filed 2023-03-28 | ||
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 1.38M shares 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | 1.38M shares 10-Q · filed 2021-08-16 | ||||
| 2020-12-31 | 169.39K shares 10-K · filed 2022-03-21 | 5.93M shares 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |